{
    "organizations": [],
    "uuid": "c6c57ef0f9f5111cf01d38368c82f4db9102f246",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acacia-pharma-listing-on-euronext/brief-acacia-pharma-listing-on-euronext-brussels-at-eur-3-60-per-share-idUSFWN1QK016",
    "ord_in_thread": 0,
    "title": "BRIEF-Acacia Pharma Listing On Euronext Brussels At Eur 3.60 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2 (Reuters) - ACACIA PHARMA LTD IPO-ACAC.L:\n* ACACIA PHARMA SUCCESSFULLY PRICES ITS INITIAL GLOBAL OFFERING AT EUR 3.60 PER SHARE RAISING EUR 40 MILLION\n* LISTING ON EURONEXT BRUSSELS AT EUR 3.60 PER SHARE Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-02T15:45:00.000+02:00",
    "crawled": "2018-03-03T17:40:51.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "acacia",
        "pharma",
        "ltd",
        "acacia",
        "pharma",
        "successfully",
        "price",
        "initial",
        "global",
        "offering",
        "eur",
        "per",
        "share",
        "raising",
        "eur",
        "million",
        "listing",
        "euronext",
        "brussels",
        "eur",
        "per",
        "share",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}